Neurocrine Bioscience buy Truist Financial Co.
Start price
07.05.26
/
50%
€127.50
Target price
07.05.27
€131.84
Performance (%)
1.37%
Price
08.05.26
€129.25
Summary
This prediction is currently active. With a performance of 1.37%, the BUY prediction by Truist_Financial_Co_ for Neurocrine Bioscience is trending in the right direction. This prediction currently runs until 07.05.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | 1.37% |
| iShares Core DAX® | 0,22 % |
| iShares Nasdaq 100 | 6,05 % |
| iShares Nikkei 225® | 5,72 % |
| iShares S&P 500 | 2,17 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Truist Financial Corporation from $140.00 to $155.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
17.02.26
17.02.26
€118.20
17.02.27
17.02.27
19.84%
08.05.26
08.05.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.75
08.01.26
08.01.26
€144.77
08.01.27
08.01.27
10.71%
08.05.26
08.05.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.35
30.10.25
30.10.25
€148.09
30.10.26
30.10.26
8.29%
08.05.26
08.05.26